Nitrous oxide-induced subacute combined degeneration of the cord: Diagnosis and treatment

Alvar Paris, Luke Lake, Albert Joseph, Anna Workman, Joseph Walton, Tom Hayton, Nikos Evangelou, James B. Lilleker, Ruth M. Ayling, David Nicholl, Alastair J. Noyce*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Recreational use of nitrous oxide (N 2 O) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has been a corresponding rise in cases of nitrous oxide-induced subacute combined degeneration of the cord (N 2 O-SACD), a pattern of myeloneuropathy usually associated with severe vitamin B 12 deficiency. This can cause serious and permanent disability in young people but, if recognised early, may be effectively treated. All neurologists should be aware of N 2 O-SACD and its treatment; however, there are currently no agreed guidelines. Based on our experience in East London, an area of high N 2 O use, we provide practical advice on its recognition, investigation and treatment.

Original languageEnglish
Pages (from-to)222-228
Number of pages7
JournalPractical Neurology
Volume23
Issue number3
Early online date22 Feb 2023
DOIs
Publication statusPublished - 1 Jun 2023

Keywords

  • B12 DEFICIENCY
  • CLINICAL NEUROLOGY
  • GAIT
  • MYELOPATHY
  • NEUROTOXICOLOGY
  • Magnetic Resonance Imaging
  • Subacute Combined Degeneration/diagnosis
  • Humans
  • Vitamin B 12/therapeutic use
  • Adolescent
  • Vitamin B 12 Deficiency/chemically induced
  • Nitrous Oxide/adverse effects

Fingerprint

Dive into the research topics of 'Nitrous oxide-induced subacute combined degeneration of the cord: Diagnosis and treatment'. Together they form a unique fingerprint.

Cite this